Evaluation of Urinary Incontinence and Knowledge Level in Individuals with Chronic Obstructive Pulmonary Disease

Abstract

Objective: The aim of this study was to investigate the relationship between COPD symptom severity and urinary incontinence (UI) symptom severity and to investigate the level of UI knowledge in individuals diagnosed with Chronic Obstructive Pulmonary Disease (COPD). Material and Methods: One hundred individuals with COPD (34 women, 66 men, age: 61.86±7.58 years, body mass index: 28.34±6.04 kg/m2) were included. Individuals were classified according to the GOLD Classification (A, B, E). The Modified Medical Research Council Dyspnea Scale (MMRC), COPD Assessment Test (CAT) and Leicester Cough Questionnaire (LCQ) were used to determine symptom severity of COPD and to examine its effect on quality of life. The presence and severity of UI with the International Consultation Incontinence Questionnaire-Short Form (ICIQ-SF), and the level of UI knowledge with the Prolapse and Incontinence Knowledge Questionnaire-UI (PIKQ-UI) were evaluated. Results: The presence of UI was found to be 45% in individuals with COPD. There was a correlation between ICIQ-SF and MMRC (rho=0.260; p=0.009), CAT (rho=0.260; p=0.009) and LCQ (rho=-0.443; p<0.001). The median PIKQ-UI score was 4 and the level of UI knowledge was found to be inadequate and below the 80% threshold. Conclusion: It was found that the presence and severity of UI in individuals with COPD were associated with the severity of dyspnea symptoms, general health status affected by COPD, cough symptoms and health-related quality of life. Incontinence knowledge was found to be low in individuals with COPD. It may be important to consider the presence of UI in the assessment, education and treatment of individuals with COPD.

Keywords

• dyspnea
• Chronic Obstructive Pulmonary Disease
• urinary incontinence
• quality of life

Kronik Obstrüktif Akciğer Hastalığı Olan Bireylerde Üriner İnkontinans ve Bilgi Düzeyinin İncelenmesi

Abstract

Amaç: Bu çalışmadaki amaç Kronik Obstrüktif Akciğer Hastalığı (KOAH) tanılı bireylerde KOAH semptom şiddeti ile üriner inkontinans (Üİ) semptom şiddeti arasındaki ilişkinin incelenmesi ve Üİ bilgi düzeyininin araştırılmasıydı. Gereç ve Yöntem: KOAH tanısı almış 100 birey (34 kadın, 66 erkek, yaş: 61,86±7,58 yıl, beden kütle indeksi: 28,34±6,04 kg/m2) dâhil edildi. Bireyler GOLD Sınıflamasına (A, B, E) göre sınıflandırıldı. KOAH’a yönelik semptom şiddetinin belirlenmesi ve yaşam kalitesi üzerine etkisinin incelenmesi için Modifiye Medical Research Council Dispne Skalası (MMRC), KOAH Değerlendirme Testi (KDT) ve Leicester Öksürük Anketi (LÖA) kullanıldı. Bireylerdeki Üİ varlığı ve şiddeti Uluslararası İnkontinans Konsültasyon Anketi-Kısa Formu (ICIQ-SF) ile, Üİ bilgi düzeyi Prolapsus ve İnkontinans Bilgi Testi-Üİ (PİBT-Üİ) ile değerlendirildi. Bulgular: KOAH tanılı bireylerin Üİ varlığının %45 olduğu görüldü. ICIQ-SF ile MMRC (rho=0,260; p=0,009), KDT (rho=0,260; p=0,009) ve LÖA (rho=-0,443; p<0,001) arasında bir ilişki tespit edildi. PİBT-Üİ medyanı 4 olup, Üİ bilgi düzeyinin %80 eşiğinin altında ve yetersiz olduğu bulundu. Sonuç: KOAH tanılı bireylerde Üİ varlığı ve şiddeti ile dispne semptom şiddetinin, KOAH sonucu etkilenen genel sağlık durumunun, öksürük semptomunun ve sağlıkla ilgili yaşam kalitesinin ilişkili olduğu bulundu. KOAH’lı bireylerde inkontinans bilgisinin düşük olduğu bulundu. KOAH tanılı bireylerin değerlendirme, bilgilendirme ve tedavide Üİ varlığının dikkate alınması önemli olabilir.

Keywords

• dispne
• Kronik Obstrüktif Akciğer Hastalığı
• üriner inkontinans
• yaşam kalitesi

References

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Prevention, Diagnosis and Management of COPD (GOLD): 2025 Report [homepage on the Internet]. c2024. [updated 2024 Nov 15; cited 2024 Dec 30]. Available from: https://goldcopd.org/wp-content/uploads/2024/11/GOLD-2025-Report-v1.0-15Nov2024_WMV.pdf.
2. Kocabas A, Hancioglu A, Turkyilmaz S, Unalan T, Umut S, Cakir B, et al. Prevalence of COPD in Adana, Turkey (BOLD-Turkey Study). Proc Am Thorac Soc. 2006;3:A543.
3. Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J. 2023;61(4):2300239. DOI: 10.1183/13993003.00239-2023.
4. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-65. DOI: 10.1164/rccm.201204-0596PP.
5. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21(1):5-26. DOI: 10.1007/s00192-009-0976-9.
6. Haukeland-Parker S, Frisk B, Spruit MA, Stafne SN, Johannessen HH. Treatment of urinary incontinence in women with chronic obstructive pulmonary disease-a randomised controlled study. Trials. 2021;22(1):900. DOI: 10.1186/s13063-021-05816-2.
7. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. Standardisation Sub-Committee of the International Continence Society. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003 Jan;61(1):37-49. DOI: 10.1016/s0090-4295(02)02243-4.
8. Lin YC, Huang CC, Lin MC, Huang ST. Chinese herbal medicine reduces the risk of urinary incontinence in patients with chronic obstructive pulmonary disease: A population-based retrospective cohort study. Int J Urol. 2020 May;27(5):415-22. DOI: 10.1111/iju.14211.

9. Battaglia S, Benfante A, Principe S, Basile L, Scichilone N. Urinary incontinence in chronic obstructive pulmonary disease: a common co-morbidity or a typical adverse effect? Drugs Aging. 2019 Sep;36(9):799-806. DOI: 10.1007/s40266-019-00687-4.
10. Hrisanfow E, Hägglund D. The prevalence of urinary incontinence among women and men with chronic obstructive pulmonary disease in Sweden. J Clin Nurs. 2011 Jul;20(13-14):1895-905. DOI: 10.1111/j.1365-2702.2010.03660.x.
11. Hirayama F, Lee AH, Binns CW, Taniguchi H, Nishimura K, Kato K. Urinary incontinence in men with chronic obstructive pulmonary disease. Int J Urol. 2008 Aug;15(8):751-3. DOI: 10.1111/j.1442-2042.2008.02093.x.
12. Hrisanfow E, Hägglund D. Impact of cough and urinary incontinence on quality of life in women and men with chronic obstructive pulmonary disease. J Clin Nurs. 2013 Jan;22(1-2):97-105. DOI: 10.1111/j.1365-2702.2012.04143.x.
13. Zhu M, Sim J, Okada C, Kim J, Abraham N. Association between respiratory disease and stress urinary incontinence: An analysis of the 2015-2020 National Health and Nutrition Examination Survey. Neurourol Urodyn. 2023 Aug;42(6):1280-9. DOI: 10.1002/nau.25217.
14. Vasconcelos CTM, Firmiano MLV, Oriá MOB, Vasconcelos Neto JA, Saboia DM, Bezerra LRPS. Women's knowledge, attitude and practice related to urinary incontinence: systematic review. Int Urogynecol J. 2019 Feb;30(2):171-80. DOI: 10.1007/s00192-018-3759-3.
15. Aydemir D, Çıtak Karakaya İ, Günay Avcı S, Gürhan Karakaya M. Psychometric properties and feasibility of three scales assessing the level of knowledge and awareness about pelvic floor health. Eur J Obstet Gynecol Reprod Biol. 2024 Oct;301:135-41. DOI: 10.1016/j.ejogrb.2024.07.035.
16. Köhler B, Lingemann J, Lüder C, Weinreich G, Teschler H. Lack of knowledge about symptoms and treatment options of urinary incontinence (UI) in patients with chronic obstructive pulmonary disease (COPD). Physiotherapy. 2015;101:e773.
17. Güngen C, Ertan T, Eker E, Yaşar R, Engin F. Standardize Mini Mental test'in Türk toplumunda hafif demans tanisinda geçerlik ve güvenilirliği [Reliability and validity of the standardized Mini Mental State Examination in the diagnosis of mild dementia in Turkish population]. Turk Psikiyatri Derg. 2002 Winter;13(4):273-81.
18. Özer Kaya D, Naz Gürşan İ, Günay Uçurum S, Emük Y, Büker N, Ongan D. Düzenli fiziksel aktivite ve egzersiz alışkanlığı olan ve olmayan üniversite öğrencilerinin fiziksel uygunluklarının karşılaştırılması: ön çalışma. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi. Eylül 2020;5(3):249-54.
19. Celenay ST, Balaban M, Kaya DO. Lateral abdominal musclethickness and contractile function in women with and withoutstress urinary incontinence. Int Urogynecol J. 2024 Feb;35(2):303-9.DOI: 10.1007/s00192-023-05636-9.
20. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA.Usefulness of the Medical Research Council (MRC) dyspnoea scaleas a measure of disability in patients with chronic obstructivepulmonary disease. Thorax. 1999 Jul;54(7):581-6. DOI:10.1136/thx.54.7.581.
21. Yorgancıoğlu A, Polatlı M, Aydemir Ö, Yılmaz Demirci N, Kırkıl G,Naycı Atış S ve ark. Reliability and validity of Turkish version ofCOPD assessment test. Tuberk Toraks. 2012;60(4):314-20. DOI:10.5578/tt.4321.
22. Kurhan F, Göktalay T, Havlucu Y, Sarı S, Yorgancıoğlu A, Çelik P, etal. The validity and reliability of the Turkish version of the LeicesterCough Questionnaire in COPD patients. Turk J Med Sci. 2018 Aug16;48(4):811-6. DOI: 10.3906/sag-1801-27.
23. Gönen NA. Leicester öksürük anketi (Leicester coughquestionnaire) (LCQ) Türkçe geçerlilik ve güvenilirliği. [uzmanlıktezi]. [Manisa]: Manisa Celal Bayar Üniversitesi; 2014. 82 p.
24. Çetinel B, Özkan B, Can G. ICIQ-SF Türkçe versiyonu validasyon(geçerlilik) çalışması. Turk J Urol. 2004 Dec;30(3):332-8.
25. Toprak Celenay S, Coban O, Sahbaz Pirincci C, Korkut Z, Birben T,Alkan A, et al. Turkish translation of the Prolapse and IncontinenceKnowledge Questionnaire: validity and reliability. Int Urogynecol J.2019 Dec;30(12):2183-90. DOI: 10.1007/s00192-019-03962-5.
26. Toprak Celenay S, Coban O, Korkut Z, Alkan A. Do community-dwelling pregnant women know about pelvic floor disorder?Women Health. 2021 Jul;61(6):609-16. DOI:10.1080/03630242.2021. 1942398.
27. Özdamar K. SPSS ile Biyoistatistik: Nisan kitabevi; 2013. 498 p.
28. Schober P, Boer C, Schwarte LA. Correlation coefficients:appropriate use and interpretation. Anesth Analg. 2018May;126(5):1763-68. DOI: 10.1213/ANE.0000000000002864.
29. Button BM, Holland AE, Sherburn MS, Chase J, Wilson JW, BurgeAT. Prevalence, impact and specialised treatment of urinaryincontinence in women with chronic lung disease. Physiother. 2019Mar;105(1):114-9. DOI: 10.1016/j.physio.2018.07.006.
30. Yavuz M, Etiler N. Addressing urinary incontinence by gender: anationwide population-based study in Turkiye. BMC Urol. 2023 Dec9;23(1):205. DOI: 10.1186/s12894-023-01388-2.
31. Bocquet L, Gravier FE, Smondack P, Prieur G, Combret Y, Muir JF, etal. Urinary incontinence in people referred for pulmonaryrehabilitation: an undisclosed issue but a real problem. Phys Ther.2021 Mar 3;101(3):pzaa217. DOI: 10.1093/ptj/pzaa217.
32. Burge AT, Lee AL, Kein C, Button BM, Sherburn MS, Miller B, et al.Prevalence and impact of urinary incontinence in men with chronicobstructive pulmonary disease: a questionnaire survey. Physiother.2017 Mar;103(1):53-8. DOI: 10.1016/j.physio.2015.11.004.
33. Li J, Zhao X, Li J, Liu Y, Li T. Knowledge of urinary incontinenceamong women 6 weeks to 1 year after delivery. Neurourol Urodyn.2024 Sep;43(7):1655-64. DOI: 10.1002/nau.25472.
34. Karaaslan Y, Karadag M, Toprak Celenay S. Pelvic floor dysfunctionsymptoms and knowledge level in obese women. Women Health.2022 Apr;62(4):293-301. DOI: 10.1080/03630242.2022.2064034.
35. Toprak Celenay S, Dusgun ES, Degirmendereli AR. High-impactssport athletes' pelvic floor knowledge, awareness, and lowerurinary tract symptoms: a cross-sectional pilot study. TurkiyeKlinikleri J Sports Sci. 2021;13(3):477-84.
36. Angın E. Kronik solunum yolu hastalığı olan bireylerde ürinerinkontinans semptomları ile konuya ilişkin bilgi ve farkındalığınincelenmesi [yüksek lisans tezi]. [Muğla]: Muğla Sıtkı KoçmanÜniversitesi; 2023. 74 p.
37. Araujo CM, de Morais NR, Sacomori C, de Sousa Dantas D.Response to: Symptoms assessed by pad test for urinaryincontinence depend on pressure generated for diagnostic testaccuracy. Neurourol Urodyn. 2022 Sep;41(7):1631-2. DOI:10.1002/nau.24991.